Medical technology assessment and the role of economic evaluation in health care

Journal of Evaluation in Clinical Practice

Volumn 2, Issue 4, 1996, Pages 287-294

  Adang, E M M ^a   Ament, A ^a   Dirksen, C D ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cost benefit; Cost effectiveness; Cost utility analysis; Economic evaluation; Medical technology; Policy making

Indexed keywords

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; COST BENEFIT ANALYSIS; ECONOMICS; EUROPE; HEALTH CARE COST; HUMAN;

COST-BENEFIT ANALYSIS; EUROPE; HEALTH EXPENDITURES; HUMANS; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 0030275652     PISSN: 13561294     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2753.1996.tb00059.x     Document Type: Review

References (29)

1. Adang E.M.M., Dirksen C.D., Engel G.L. & Baeten C.G.M.I. (1995) Medical technology assessment: economic evaluation of new technologies. British Journal of Hospital Medicine 53, 563-566.
2. Baeten C.G.M.I., Geerdes B.P., Adang E.M.M., Heineman E., Konsten J., Engel G.L., Kester A.D.M., Spaans F. & Soeters P.B. (1995) Anal dynamic graciloplasty in the treatment of intractable faecal incontinence. New England Journal of Medicine 332, 1600-1605.
3. Banta H.D. & Luce B.R. (1993) Health Care Technology and its Assessment. Oxford University Press, Oxford.
4. Belien P. (1996) Healthcare Reform in Europe. Pharmacoeconomics 10, 94-99.
5. Bos M. (1994) Health care technology in the Netherlands. Health Policy 30, 207-255.
6. Culyer A.J. (1992) The morality of efficiency in health care-some uncomfortable implications. Health Economics 1, 7-18.
7. Department of Health (1994) Government Response to the Second Report from the Health Committee. House of Commons Session 1993-1994. HMSO, London.
8. Drummond M. (1992) Cost-effectiveness guidelines for reimbursement of pharmaceuticals: Is economic evaluation ready for its enhanced status? Health Economics 1, 85-92.
9. Drummond M., Torrance G., Mason J. (1993) Cost-effectiveness league tables: more harm than good? Social Science and Medicine 37, 33-40.
10. Drummond M.F., Stoddart G.L. & Torrance G.W. (1987) Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, Oxford.
11. Dutch Minister of Health (1995) Letter, vergaderjaar 1995-1996, 24 126, nr. 9.
12. Elixhauser A., Luce B.R., Taylor W. & Reblando J. (1993) Cost benefit and cost effectiveness analyses from 1979 and 1990: A bibliography. Medical Care 31(S), 1-149.
13. Freemantle N., Henry D., Maynard A. & Torrance G. (1995) Promoting cost effective prescribing. British Medical Journal 310, 955-6.
14. Froberg D.G. & Kane R.L. (1989) Methodology for measuring health-state preferences - II: scaling methods. Journal of Clinical Epidemiology 42, 459-471.
15. Health Committee (1994) Priority Setting in the NHS: the NHS Drugs Budget, Vol. I. Report. House of Commons Session 1993-94. HMSO, London.
16. Laupacis A., Feeny D., Detsky, A.S. & Tugwell P.X. (1992) How attractive does a new technology have to be to warrant adoption and utilisation? Tentative guidelines for using clinical and economic evaluations. Canadian Medical Association Journal 146, 473-481.
17. Luce B.R. & Brown R.E. (1995) The use of technology assessment by hospitals, health maintenance organisations, and third-party payers in the United States. International Journal of Technology Assessment in Health Care 11, 79-92.
18. Mishan E.J. (1988) Cost-Benefit Analyses, 4th edn. Routledge, London.
19. Office of Technology Assessment (1978) Assessing the Efficacy and Safety of Medical Technologies. Government Printing Office, Washington, DC, USA.
20. Reinhardt V.E. (1996) The new social contract for health care: should economists write it or merely describe it? In Abstracts of the International Health Economics Association Inaugural Conference. Quality and Inequality: What Care, Whose Costs, Whither Health, May 19-23 1996, Vancouver. International Health Economics Association, Vancouver.
21. Robinson R. (1993) Economic Evaluation and Health Care: The policy context. British Medical Journal 307, 994-996.
22. Rubenstein E.S. (1994) Comparative Spending of Governments. The Right Data. National Review Books, New York.
23. Salkeld G., Davey P. & Arnolda G. (1995) A critical review of health-related economic evaluations in Australia: implications for health policy. Health Policy 31, 111-125.
24. Stalhammar N. (1996) An empirical note on willingness to pay and starting point bias. Medical Decision Making 16, 242-247.
25. Strosberg M.A., Wiener J.M., Baker R. & Fein I.A. (eds) (1992) Rationing America's Medical Care: the Oregon Plan and Beyond. The Brookings Institution, Washington, DC.
26. Towse A., Wells N. (1995) Cost-effectiveness studies may not be cost-effective [letter]. British Medical Journal 126, 311.
27. US Department of Health and Human Services, Public Health Service (1996) Cost Effectiveness in Health and Medicine. Oxford University Press, Oxford.
28. van Hout B., Bonsel G., Habbema D., van der Maas P. & de Charro F. (1993) Heart transplantation in the Netherlands; costs, effects and scenarios. Journal of Health Economics 12, 73-93.
29. Williams A. (1985) Economics of coronary artery bypass grafting. British Medical Journal 291, 326-329.